Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support.

From the week of November 18th, we are planning to work on 14 projects, including:

Reimbursement

1. Working on reimbursement and procedure volume analysis project for multiple technologies in obstetrics and gynecology in France, Germany, Italy, and Spain
2. Working on policy analysis project, including qualitative interviews, in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 
3. Delivering the reimbursement strategy project for several technologies in ophthalmological, urological, and oncological fields in the Nordic region (Denmark, Finland, Norway, and Sweden)
4. Working on the educational materials on the reimbursement system in the Netherlands
5. Initiating work on the reimbursement analysis for therapeutic drug monitoring in England and France
6. Initiating work on the reimbursement analysis for parenteral drug delivery systems in outpatient specialist and home-based care in Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Spain, Sweden
7. Initiating work on reimbursement strategy for ostomy products in France and Germany 

HEOR

1. Working on the development of an HTA national submission dossier in Sweden
2. Working on the development of a health economic model for neurovascular technology in Belgium, England, France, Germany, Italy, and Spain
3. Working on adaptations of the health economic model for in-vitro diagnostic tests in infectious disease areas in France and Spain
4. Working on the development of a health economic model for neuromonitoring technology in England
5. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain
6. Initiating the Evidence Gap Analysis for two technologies in the nephrology field
7. Working on the development of the reimbursement application for technology in the neurovascular field in Ireland

Let us know if you need any market access or HEOR support for your medical technology in Europe.